DOJ reportedly has ‘significant concerns’ about Aetna-Humana merger

Reuters is reporting the U.S. Department of Justice (DOJ) has concerns about the antitrust implications of Aetna’s $34 billion proposed acquisition of Humana, according to an anonymous source within the department.

State insurance regulators in Missouri and California have asked the DOJ to block the deal for its “anticompetitive impact,” particularly based on the Medicare Advantage market share the combined insurer would control.

To read more about when and why the DOJ may get in the way of the proposed merger, click on the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”